QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
In Vitro Diagnostics (IVD) Market to Reach USD 126.6 Billion by 2032, at 4.8% CAGR, Driven by Rising Prevalence of Chronic Diseases and Advances in Diagnostic Technologies – S&S Insider [Yahoo! Finance]
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm